Dose Exploration Study of GSK4532990 in Participants With NASH or Suspected NASH
Status:
Recruiting
Trial end date:
2025-06-27
Target enrollment:
Participant gender:
Summary
The purpose of this study is to understand how the drug GSK4532990 is processed in the body
(pharmacokinetics) and how it works in the liver (pharmacodynamics) as well as to ensure it
is safe and well-tolerated. The total study duration for each participant will be
approximately 24 weeks.